Stocks and Investing Stocks and Investing
Thu, November 19, 2020

David Lewis Maintained (ABT) at Buy with Increased Target to $121 on, Nov 19th, 2020


Published on 2024-10-27 14:49:29 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $117 to $121 on, Nov 19th, 2020.

David has made no other calls on ABT in the last 4 months.



There are 11 other peers that have a rating on ABT. Out of the 11 peers that are also analyzing ABT, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $115 on, Thursday, October 22nd, 2020


These are the ratings of the 10 analyists that currently disagree with David


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $114 on, Thursday, October 22nd, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $118 on, Thursday, October 22nd, 2020
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $122 on, Thursday, October 22nd, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $120 on, Wednesday, October 21st, 2020
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $113 on, Monday, October 19th, 2020
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020
  • Mike Polark of "Wolfe Research" Initiated at Buy and Held Target at $124 on, Friday, September 11th, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Friday, August 28th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
Contributing Sources